These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9061299)

  • 21. [Chemoprevention in non-small cell bronchial cancers].
    van Zandwijk N
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S51-3. PubMed ID: 12538937
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemoprevention of skin cancer.
    Richmond E; Viner JL
    Semin Oncol Nurs; 2003 Feb; 19(1):62-9. PubMed ID: 12638382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention of head and neck cancer.
    Voravud N
    J Med Assoc Thai; 1996 Mar; 79(3):185-93. PubMed ID: 8708501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is There a Future for Chemoprevention of Prostate Cancer?
    Bosland MC
    Cancer Prev Res (Phila); 2016 Aug; 9(8):642-7. PubMed ID: 27099271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived benefits of and barriers to participation in a phase I/II colon cancer chemoprevention trial.
    Hudmon KS; Love RR; Chamberlain RM
    J Cancer Educ; 1999; 14(2):83-7. PubMed ID: 10397482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Cancer: Novel Concepts for the Oral Health Care Practitioner.
    Messadi DV
    J Calif Dent Assoc; 2016 Feb; 44(2):82-4. PubMed ID: 26930750
    [No Abstract]   [Full Text] [Related]  

  • 27. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention: from research to clinical oncology.
    Veronesi U; Bonanni B
    Eur J Cancer; 2005 Sep; 41(13):1833-41. PubMed ID: 16061373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention in gastroenterology.
    Hull M; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):443. PubMed ID: 22122761
    [No Abstract]   [Full Text] [Related]  

  • 30. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture.
    Hong WK; Lippman SM; Wolf GT
    Cancer Res; 1993 Nov; 53(21):5113-20. PubMed ID: 8221647
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon.
    Pereira MA; Khoury MD
    Cancer Lett; 1991 Dec; 61(1):27-33. PubMed ID: 1837244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From carcinogenesis to clinical interventions for cancer prevention.
    Greenwald P
    Toxicology; 2001 Sep; 166(1-2):37-45. PubMed ID: 11518609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.
    Bauman JE; Grandis J
    JAMA Oncol; 2016 Feb; 2(2):178-9. PubMed ID: 26540592
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprevention of cancer--focusing on clinical trials.
    Kakizoe T
    Jpn J Clin Oncol; 2003 Sep; 33(9):421-42. PubMed ID: 14594936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
    Parnes HL; House MG; Kagan J; Kausal DJ; Lieberman R
    J Urol; 2004 Feb; 171(2 Pt 2):S68-74; discussion S75. PubMed ID: 14713758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical evaluation of cancer chemoprevention agents: defining and contrasting phase I, II, and III objectives.
    Goodman GE
    Cancer Res; 1992 May; 52(9 Suppl):2752s-2757s. PubMed ID: 1563007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of beta-carotene and antioxidant vitamins in the prevention of oral cancer.
    Garewal HS
    Ann N Y Acad Sci; 1992 Sep; 669():260-7; discussion 267-8. PubMed ID: 1444031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.